The authors studied the ability of superparamagnetic iron oxide nanoparticles-labeled Wharton’s jelly of the human umbilical cord-derived mesenchymal stem cells to carry the green fluorescent protein (GFP) gene to cutaneous injury sites in a murine model. The results showed that GFP could be intensively detected around the wound in vivo 24 hours after the cells were injected. [BMC Cell Biol]
Full Article

The authors wish to increase the awareness of oncology practitioners to the availability of alternative donor stem cell transplants for patients with hematologic malignancies. Despite new agents, stem cell transplant remains the only curative therapy for many patients with acute and chronic leukemia, myelodysplasia, and lymphoma. Given the variety of different donor stem cell sources available, nearly every patient who needs an allogeneic stem cell transplant will have a donor. [Oncologist]
Abstract

Visit our
reviews
page to see a complete list of reviews in
the cord blood research field.

StemCyte, Inc. announced a renewed strategic partnership with the Neonatal Research Institute at Sharp Mary Birch Hospital for Women & Newborns. The strategic partnership designed to enhance resources for collection, processing and banking of this vital potentially life-saving resource of cord blood stem cells as well as their availability for new research. [StemCyte, Inc. (PR Newswire Association LLC.)]
Press Release

The University of Kansas Cancer Center has announced that it will join a consortium with the Dana-Farber Cancer Institute, in collaboration with The Leukemia & Lymphoma Society, to bring clinical trials testing innovative blood cancer therapies to Kansas City. [University of Kansas Cancer Center]
Press Release

The owner of the vast science-citation database Web of Science — Clarivate Analytics — is buying up a firm that has gathered hundreds of thousands of peer-review records, in a deal that could lead to new ways of organizing scientific peer review and preventing peer-review fraud. [Nature News]
Editorial

The blacklist is dead; long live the blacklist. Five months after a widely read blog listing possible ‘predatory’ scholarly journals and publishers was shut down, another index of untrustworthy titles is appearing — although this version will be available only to paying subscribers. [Nature News]
Editorial

An effort to test whether reviewers are biased against blacks applying for grants from the National Institutes of Health (NIH) is proving to be much harder to carry out than expected. [ScienceInsider]
Editorial